PL3431609T3 - Sposób diagnozowania raka jelita grubego - Google Patents
Sposób diagnozowania raka jelita grubegoInfo
- Publication number
- PL3431609T3 PL3431609T3 PL17181646T PL17181646T PL3431609T3 PL 3431609 T3 PL3431609 T3 PL 3431609T3 PL 17181646 T PL17181646 T PL 17181646T PL 17181646 T PL17181646 T PL 17181646T PL 3431609 T3 PL3431609 T3 PL 3431609T3
- Authority
- PL
- Poland
- Prior art keywords
- diagnosis
- colorectal cancer
- colorectal
- cancer
- Prior art date
Links
- 206010009944 Colon cancer Diseases 0.000 title 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17181646.5A EP3431609B1 (en) | 2017-07-17 | 2017-07-17 | Method of diagnosis of colorectal cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3431609T3 true PL3431609T3 (pl) | 2020-11-02 |
Family
ID=59363020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17181646T PL3431609T3 (pl) | 2017-07-17 | 2017-07-17 | Sposób diagnozowania raka jelita grubego |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210130904A1 (pl) |
| EP (1) | EP3431609B1 (pl) |
| JP (2) | JP6989863B2 (pl) |
| ES (1) | ES2785682T3 (pl) |
| HU (1) | HUE048369T2 (pl) |
| PL (1) | PL3431609T3 (pl) |
| WO (1) | WO2019015702A1 (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11660317B2 (en) | 2004-11-08 | 2023-05-30 | The Johns Hopkins University | Compositions comprising cardiosphere-derived cells for use in cell therapy |
| US9828603B2 (en) | 2012-08-13 | 2017-11-28 | Cedars Sinai Medical Center | Exosomes and micro-ribonucleic acids for tissue regeneration |
| US11357799B2 (en) | 2014-10-03 | 2022-06-14 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy |
| EP3402543B1 (en) | 2016-01-11 | 2021-09-08 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction |
| US11351200B2 (en) | 2016-06-03 | 2022-06-07 | Cedars-Sinai Medical Center | CDC-derived exosomes for treatment of ventricular tachyarrythmias |
| EP3515459A4 (en) | 2016-09-20 | 2020-08-05 | Cedars-Sinai Medical Center | CELLS DERIVED FROM CARDIOSPHERES AND THEIR EXTRACELLULAR VESICLES TO DELAY OR REVERSE AGING AND AGE-RELATED DISORDERS |
| US11759482B2 (en) | 2017-04-19 | 2023-09-19 | Cedars-Sinai Medical Center | Methods and compositions for treating skeletal muscular dystrophy |
| PL3431609T3 (pl) * | 2017-07-17 | 2020-11-02 | Masarykova Univerzita | Sposób diagnozowania raka jelita grubego |
| US11660355B2 (en) | 2017-12-20 | 2023-05-30 | Cedars-Sinai Medical Center | Engineered extracellular vesicles for enhanced tissue delivery |
| EP3749344A4 (en) | 2018-02-05 | 2022-01-26 | Cedars-Sinai Medical Center | METHODS OF THERAPEUTIC USE OF EXOSOMES AND Y-RNAS |
| CN111321222B (zh) * | 2018-12-17 | 2024-01-19 | 北京大学肿瘤医院内蒙古医院(内蒙古医科大学附属肿瘤医院、内蒙古自治区肿瘤医院、内蒙古自治区癌症中心) | 用于结直肠癌无创诊断的血清piRNA标志物及检测试剂盒 |
| CN109913461B (zh) * | 2019-04-01 | 2023-05-02 | 中国医科大学附属口腔医院 | 根尖牙乳头干细胞外泌体piRNA生物标志物及其筛选应用 |
| JP2023527766A (ja) * | 2020-05-19 | 2023-06-30 | シーダーズ―シナイ メディカル センター | エキソソーム由来のＰＩＷＩ－ｉｎｔｅｒａｃｔｉｎｇ ＲＮＡおよびその使用方法 |
| EP4130296A1 (en) * | 2021-08-03 | 2023-02-08 | Deutsches Krebsforschungszentrum - Stiftung des öffentlichen Rechts / Universität Heidelberg | Cancer prediction |
| CN114790482A (zh) * | 2022-05-31 | 2022-07-26 | 深圳市诺亚基因科技有限公司 | 一种筛查或辅助筛查结直肠癌的方法及其使用的miRNA组合 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7501243B2 (en) | 2001-02-21 | 2009-03-10 | Novartis Vaccines And Diagnostics, Inc. | Detection of colon or breast cancer by measuring TTK polypeptide expression |
| WO2004071267A2 (en) | 2003-02-11 | 2004-08-26 | Roche Diagnostics Gmbh | Diagnosis of colorectal cancer by detection of nicotinamide n-methyltransferase in a stool sample |
| EP1601969A2 (en) | 2003-03-08 | 2005-12-07 | Auvation Ltd | Markers for colorectal cancer |
| JP2006528340A (ja) | 2003-08-07 | 2006-12-14 | エフ．ホフマン−ラ ロシュ アーゲー | 結腸直腸癌に対するマーカーとしてのタンパク質酸性リボソームタンパク質ｐｏ（ｒｌａ−０）の使用 |
| WO2005015234A1 (en) | 2003-08-11 | 2005-02-17 | Roche Diagnostics Gmbh | Use of protein sahh as a marker for colorectal cancer |
| KR101073875B1 (ko) | 2008-11-28 | 2011-10-14 | 한국생명공학연구원 | 대장암 진단 마커 및 이를 이용한 대장암 진단방법 |
| WO2011161960A1 (en) * | 2010-06-23 | 2011-12-29 | Oncotherapy Science, Inc. | C1orf59 for target genes of cancer therapy and diagnosis |
| CN103627705B (zh) * | 2013-10-28 | 2016-02-24 | 南京医科大学 | 与膀胱癌相关的piRNA生物标志物及其应用 |
| CN105483218B (zh) * | 2015-12-11 | 2018-08-07 | 南京大学 | 检测和/或预测男性生殖功能障碍的精浆piRNA标志物或其组合及其应用 |
| PL3431609T3 (pl) * | 2017-07-17 | 2020-11-02 | Masarykova Univerzita | Sposób diagnozowania raka jelita grubego |
-
2017
- 2017-07-17 PL PL17181646T patent/PL3431609T3/pl unknown
- 2017-07-17 ES ES17181646T patent/ES2785682T3/es active Active
- 2017-07-17 HU HUE17181646A patent/HUE048369T2/hu unknown
- 2017-07-17 EP EP17181646.5A patent/EP3431609B1/en active Active
-
2018
- 2018-07-13 US US16/629,520 patent/US20210130904A1/en not_active Abandoned
- 2018-07-13 WO PCT/CZ2018/050037 patent/WO2019015702A1/en not_active Ceased
- 2018-07-13 JP JP2020502467A patent/JP6989863B2/ja not_active Expired - Fee Related
-
2021
- 2021-03-04 JP JP2021034649A patent/JP2021090451A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20210130904A1 (en) | 2021-05-06 |
| ES2785682T3 (es) | 2020-10-07 |
| JP2020527047A (ja) | 2020-09-03 |
| HUE048369T2 (hu) | 2020-07-28 |
| JP2021090451A (ja) | 2021-06-17 |
| EP3431609A1 (en) | 2019-01-23 |
| EP3431609B1 (en) | 2020-02-12 |
| WO2019015702A1 (en) | 2019-01-24 |
| JP6989863B2 (ja) | 2022-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE048369T2 (hu) | Diagnosztikai eljárás végbélrák kimutatására | |
| IL275663A (en) | Cancer treatment methods | |
| ZA201804227B (en) | Methods of treating cancer | |
| IL255189A0 (en) | Cancer treatment methods | |
| IL256025A (en) | Methods of diagnosing and treating cancer | |
| GB201511152D0 (en) | Method of diagnosing bladder cancer | |
| GB2545361B (en) | Methods of assessing colorectal cancer status | |
| SG10201801562PA (en) | Combination method for treatment of cancer | |
| IL267675A (en) | A method for treating advanced cancer expressing her2 | |
| IL262005A (en) | Methods of treating cancer in children | |
| EP3298145A4 (en) | Method of diagnosis of breast cancer | |
| ZA201908539B (en) | Method of treatment of cancer | |
| SG10201913528PA (en) | Methods of diagnosing cancer | |
| GB201814350D0 (en) | Diagnosis of cancer | |
| GB201513989D0 (en) | Method of diagnosis of dysphagia | |
| EP3183578B8 (en) | Methods for the early detection of colorectal cancer | |
| SG11201701076TA (en) | Diagnosis of cancer | |
| GB201717945D0 (en) | Method for treatment of cancer | |
| SG11202005163PA (en) | Methods of treating cancer | |
| PT3298165T (pt) | Método e kit para diagnóstico de cancro colorretal | |
| EP3389670A4 (en) | METHODS OF TREATING BREAST CANCER | |
| GB201513188D0 (en) | Method of tomography | |
| IL269123A (en) | Methods of treating cancer | |
| GB201509658D0 (en) | Method of diagnosis | |
| EP3102940A4 (en) | Anti-metalloprotease antibody for diagnosis and treatment of cancers |